Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0011570 (depression)
 172,036 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Not all side-effects are undesirable side-effects of a treatment. Under certain conditions allergic side-effects during the therapy of phasic psychotics affect a turn in the course of the basic illness and bring a premature end to depression. As a result of the observation of a sudden cure of a deep vital depression in a 73 year old patient in direct chronological connection with the appearance of an allergic urticaria, studies were carried out, in the 8 years following, of a total of 18 cases of similar circumstances; during the treatment of an endogenous depression the development of intercurrent allergic skin reactions showed: in 6 cases the psychosis completely disappeared with the development of the urticaria; in 8 cases the symptoms were considerably relieved so that only the remains of vegetative disorders persisted; in 4 cases no effect could be determined. In 2 cases the same allergic reaction was consciously provoked by a reapplication of the medicaments concerned during a following depressive phase; again with favourable results since under these conditions coincidences are not very probable, the conclusion can be made, and experimentally supported, that allergic drug reactions may be employed in the course of depressions, with careful avoidance of complications.
 ...
PMID:[Favorable, unfavorable and indifferent side effects of pharmacotherapy of psychoses]. 14 3

Patients receiving diagnoses of 'psychotic' and 'neurotic' depression do not differ significantly in their pre-morbid experience of life events and difficulties of aetiological significance. Some aetiological differences emerge when the two groups are subdivided into their more and less extreme halves along a distribution of discriminant function scores, but these differences are not substantial. Reallocation of the extreme 20% of each diagnostic group (who are likely misclassifications) into the other group tends to enlarge these 'aetiological' differences but they are still slight. Comparison of 'endogenous' patients (those without severe life events or major difficulties) with 'reactive' patients reveals a slight tendency for the 'endogenous' group to have a higher frequency of psychotic-type symptoms. Apart from age and experience of 'past loss', no further significant differences were found in the background characteristics of depressed patients diagnosed as 'psychotic' and those diagnosed 'neurotic'.
 ...
PMID:Psychotic and neurotic depression. Part 3. Aetiological and background factors. 16 3

Information which has emerged thus far relates to the overall transmitter mechanisms of sleep. The data, while conflicting, point to the involvement of many neuroregulators at numerous integrative levels of the process. However the long term question still remain: what triggers and maintain sleep, what stops sleep, what occurs to the body and brain during sleep--in essence, why sleep? These questions are now problems for behavioral neurochemists, whereas in a previous era, they were problems for philosophers. Unfortunately, our answers to date, while in another idiom, have hardly been more complete or satisfying. To answer these questions, it will be necessary to understand, in detail, the manner in which neurobiochemical processes relate to the functional physiology of sleep. Although existing studies have given invaluable insight into the neurochemical anatomy of sleep, we have only recently acquired the technical and biochemical expertise necessary to investigate sleep as it occurs normally. Future research must focus on the dynamic changes associated with the regulatory mechanisms of neurotransmitters. Many questions can be asked. With sleep transitions, what changes occur in transmitter content, synthesis, or release? Are there changes in metabolic pathways, reflecting a shift from intra- to interneuronal metabolism? What changes occur in pre- and postsynaptic neurotransmitter receptors to affect sensitivity? What constraints do genetic (245) and environmental (246) factors impose upon these mechanisms? Knowledge of such parameters will allow us to construct more complete models of the neuroregulatory basis of sleep and waking. However, as we acquire this knowledge, we must avoid the temptation of assuming causation when the evidence merely shows correlation. Neuroregulation are involved in the control of number different behaviors; and, at present, we have few, if any, methods of establishing causative links between a specific neuroregulator and a specific behavioral state. Yet, even without an understanding of what "causes" sleep, we may be able to develop pharmacological agents which permits discrete alteration of sleep mechanisms in a more physiological and specific manner. This potential for manipulation of sleep is of obvious importance in illnesses such as insomnia, narcolepsy, and sleep apnea (247, 248). In addition, it may be valuable in the treatment of such conditions as psychosis and depression, where sleep disturbances are an important component of the illness. For example, delirium tremens might be best understood as a psychotic episode which is the result of an aspect of sleep emerging into wakefulness. The range and breadth of both the basic questions and the potential application of sleep research portend an exciting future for this field.
 ...
PMID:Neuroregulators and sleep mechanisms. 16 54

On the basis of two EEG sleep criteria, REM latency and REM activity, the authors achieved 81% accuracy in distinguishing between 47 patients with primary depression and 48 patients with secondary depression using discriminant analysis. Sleep efficiency, the percentage of delta sleep, and the percentage of REM sleep discriminated between psychotic and nonpsychotic subgroups in the group with primary depression with 75% accuracy. REM activity and intermittent nocturnal awakening accurately discriminated two subtypes of patients with secondary depression at a level of 81%. These results suggest that EEG sleep measurements can yield significant data to aid in differential diagnosis in psychiatry.
 ...
PMID:The application of EEG sleep for the differential diagnosis of affective disorders. 20 Nov 74

In the last decade all night EEG sleep research has attempted to delineate the sleep features most characteristics of depressive states occurring in adult life. We have reported that EEG sleep variables could be used to verify a diagnostic classification for affective syndromes. This EEG sleep generated schema significantly dichotimized each major clinical category using only two or three EEG sleep measures. REM latency and REM density were sufficient to separate out primary from secondary depressed patients. Sleep efficiency, REM sleep percent, and delta sleep percent discriminated between the psychotic and nonpsychotic subgroups in the primary depressive group. Furthermore, EEG sleep variables separated secondary depression with concurrent medical disease from secondary depression without medical disease using REM activity and intermittent nocturnal awakening as the requisite variables of discrimination. Other ongoing investigations have established that the REM intensity of the first REM period is increased in primary depression. The search for EEG sleep correlates of clinical response in depressed patients receiving tricyclic antidepressants has suggested that, the more rapid the suppression of REM sleep, the more likely that the patient will respond to tricyclic antidepressants. Finally, clinical response appears to be associated with a period of sustained elevation of REM latency.
 ...
PMID:Application of EEG sleep for the differential diagnosis and treatment of affective disorders. 20 49

This study attempted to replicate previous work which used discriminant analysis to predict attrition from an outpatient alcoholism treatment program. The MMPI-168 and Rotter's locus of control scale were administered to a sample of inpatient male alcoholics who later entered outpatient treatment. The MMPI-168 was scored using 5 factor-analytically derived measures, Depression, Somatization, Low Morale, Psychotic Distortion and Acting Out. Both studies found Depression to be the strongest predictor of attrition after controlling for Somatization. Internal locus of control was also related to attrition. The utility of discriminant analysis in predicting outcome from personality data and the ramifications for treatment is discussed.
 ...
PMID:The use of multivariate personality strategies in predicting attrition from alcoholism treatment. 21 68

Violence is a symptom of an underlying mental state such as a psychosis, a characterological problem, or brain dysfunction. Thus drugs used to treat aggression in man exert effects by their specific pharmacological actions (e.g., antipsychotic, anticonvulsant). Most literature to date has dealt with animals and human models of aggression and lacks conceptual clarity. Aggression differs from depression, a coherent clinical entity, in its etiological diversity and its paroxysmal or impulsive basis, and this may account for the relationship seen in literature linking violence to epilepsy; yet literature on anticonvulsants is equivocal with regard to beneficial effects on aggression. Lithium has been shown to have positive effects, although its mode of action is unclear. A variety of antipsychotic agents and minor tranquilizers have been mentioned. Central nervous system stimulants have been found useful to treat hyperkinetic syndromes in both children and adults where aggression is a symptom. Hormonal agents are discussed. Drug treatment of aggression should not obscure the need for verbal therapies, and social and environmental factors should always be regarded.
 ...
PMID:Conceptual issues in the use of drugs for the treatment of aggression in man. 23 9

A strategy is presented for biological psychosis research with neuroleptics acting as a point of crystallisation like antidepressants do in biological depression research. The neuroleptics chlorpromazine, haloperidol and oxypertine were studied, and it was found that they influence central catecholamine (CA) metabolism in man. An increased central dopamine (DA) turnover was found to occur in psychotic disorders, mostly in the form of motor agitation. As the first of a planned series of studies, chlorpromazine with presumed ability to reduce both DA-ergic and noradrenaline (NA)-ergic transmission and oxypertine as a more selective blocker of NA-ergic transmission were selected for comparison. The overall therapeutic effect of oxypertine was inferior to that of chlorpromazine, whereas oxypertine proved more effective in cases where loss of initiative was predominant. On the other hand, chlorpromazine exerted a more marked influence on extrapyramidal motor functions than oxypertine. In chronic psychotic disorders with inertia, oxypertine thus seems to be a neuroleptic which is strong enough to prevent exacerbation of delusions and hallucinations while at the same time increasing the level of motivation. These findings were in accordance with our predictions. The comparative study is illustrative of the practical significance of the research approach in this study: The biochemical action profile of a neuroleptic seems to be a more reliable indicator of its clinical action than does its chemical structure.
 ...
PMID:Biochemical research into psychosis. 23 63

The aim of this study was to review six nurse-rating schedules to evaluate their suitability for a British psychiatric unit and current nursing practice. They were compared for their reliability, their concordance with psychiatric ratings and their acceptability to the nursing staff. It was found that psychiatric and nursing observations corresponded over a wide area of psychopathology: anxiety, tension, depression, hostility, preoccupation with hypochondriacal, grandiose and self-depreciatory ideas, hallucinosis, thought disorders, mannerisms, retardation, emotional withdrawal, hypomanic activity and uncooperative behaviour. These were adequately covered by two of the scales, the Brief Psychiatric Rating Scale (BPRS) and the Psychotic Inpatient Profile (PIP), which together took 7 1/2 minutes to complete. Another of the schedules studied, the Nursing Rating Scale (Hargreaves), also had relatively high reliability and a broad effective range.
 ...
PMID:Nurse-rating of psychotic behaviour. 25 34

After the introduction of the term "Zwangsvorstellungen" (compulsive ideas) into german psychiatry in 1867, there were intensive psychopathological discussions concerning the role of the affective component of this disturbance. The conviction that an affective causation of compulsion has to be repudiated, that a primary compulsive idea is just followed by a secondary affect, contrasted with the belief that alterations of mood are a prerequisite of compulsive symptoms. The latter hypothesis led to the identification of a typical course of illness in the compulsive depressions. After a short review of Lauter's casuistry, some of our own cases are presented. A differentiation between two types of compulsive depression seems to fulfill the requirements of the clinic. The distinguishing criterion is the pattern of the premorbid personality. To the widespread therapeutic pessimism we oppose various psychotherapeutic techniques for the treatment of non-psychotic compulsive phenomenal; for the manifestations occurring in the course of psychotic illnesses, the appropriate psychotropic drugs will be used in the first place, although they are of limited importance in these types of illness which oppose serious difficulties to all methods of treatment.
 ...
PMID:[On the nosological position of the obsessional-compulsive depressions (author's transl)]. 26 Jul 10


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>